Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03998189 · ClinicalTrials.gov registry record · NA
Metabolic and Microbial Profiling of Lung Cancer
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03998189 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 1 participants.
The verdict
NCT03998189, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This pilot study will establish non-invasive sample collections, including breath, saliva, blood and urine pre-surgery and at the participant's one-month post-surgery follow-up visit. Participants with suspected non-small cell lung cancer (NSCLC) stage I-III will be recruited.
Interventions
- OTHER Urine Collection
- OTHER Blood Collection
- OTHER Saliva Collection
- OTHER Breath Collection
- OTHER Tumor Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2021-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03998189
The ClinicalTrials.gov registry entry for NCT03998189 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Urine Collection is the first listed.
NCT03998189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03998189 about?
NCT03998189 is a clinical study titled "Metabolic and Microbial Profiling of Lung Cancer". This pilot study will establish non-invasive sample collections, including breath, saliva, blood and urine pre-surgery and at the participant's one-month post-surgery follow-up visit. Participants with suspected non-small cell lung cancer (NSCLC) stage I-III will be recruited.
What is the current status of trial NCT03998189?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-10-11. Estimated completion is 2021-06-21.
What interventions are being tested in trial NCT03998189?
The interventions under investigation include: Urine Collection (OTHER), Blood Collection (OTHER), Saliva Collection (OTHER), Breath Collection (OTHER), Tumor Collection (OTHER).
Who is sponsoring clinical trial NCT03998189?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.